N-phenylacetylphenylalanine

potentially useful in treatment of sickle cell anemia; RN given refers to (L)-isomer

Also Known As:

N-phenylacetyl-L-phenylalanine; N-phenylacetylphenylalanine, (D)-isomer

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Sickle Cell Anemia (Hemoglobin S Disease) 05/01/1984 - "N-Phenylacetyl-L-phenylalanine (PAP) and L-phenylalanyl-3-aminopyridine ( PAPA ) are biaromatic agents with properties that make them suitable candidates for the development of a useful therapeutic agent for the treatment of sickle cell disease. "

1.	phenylalanyl-3-aminopyridine